You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
AstraZeneca
Express Scripts
Boehringer Ingelheim
McKinsey

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Chlorpheniramine maleate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for chlorpheniramine maleate and what is the scope of patent protection?

Chlorpheniramine maleate is the generic ingredient in twenty-three branded drugs marketed by Aurolife Pharma Llc, Glaxosmithkline, Schering Plough, Bel Mar, Elkins Sinn, Watson Labs, Schering, Pharm Assoc, Bayer Healthcare Llc, Avanthi Inc, Alza, Bayer Pharms, Anabolic, Bell Pharma, Impax Labs, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Newtron Pharms, Panray, Pharmavite, Pharmeral, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Vitarine, West Ward, Halsey, Lannett, Mainpointe, Acella, Tris Pharma Inc, Persion, Mayne Pharma Inc, Paddock Llc, Torrent, Graham Dm, Novartis, Schwarz Pharma, Fisons, and Cent Pharms, and is included in sixty-two NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for chlorpheniramine maleate. Two suppliers are listed for this compound.

Drug Prices for chlorpheniramine maleate

See drug prices for chlorpheniramine maleate

Drug Sales Revenue Trends for chlorpheniramine maleate

See drug sales revenues for chlorpheniramine maleate

Recent Clinical Trials for chlorpheniramine maleate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sephoris Pharmaceuticals LLCPhase 2
Sino-American Tianjin Smith Kline & French Laboratories LtdPhase 4
GlaxoSmithKlinePhase 4

See all chlorpheniramine maleate clinical trials

Medical Subject Heading (MeSH) Categories for chlorpheniramine maleate

US Patents and Regulatory Information for chlorpheniramine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmeral CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 083753-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TELDRIN chlorpheniramine maleate CAPSULE, EXTENDED RELEASE;ORAL 017369-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Schering Plough CHLOR-TRIMETON chlorpheniramine maleate INJECTABLE;INJECTION 008826-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for chlorpheniramine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994   Start Trial   Start Trial
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994   Start Trial   Start Trial
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.